Preventive Care
Conference Coverage
New European guidelines on CVD prevention
A chief goal of the guideline task force was to create a single CVD prevention guideline for everyone.
News
Politics or protection? What’s behind the push for boosters?
Two high-level FDA officials have abruptly resigned amid reports that they were angry that the Biden administration was making decisions that...
News
Breakthrough infections twice as likely to be asymptomatic
New research found that of 1.2 million adults who received at least one dose of either the Pfizer, Moderna, or AstraZeneca vaccine, fewer than 0.5...
Latest News
Pandemic-related drops in breast cancer screening hit hardest among medically underserved
Drops in screening were less dramatic than national declines previously reported, possibly because of the American Cancer Society–directed CHANGE...
News
Vax campaign averted nearly 140,000 U.S. deaths through early May: Study
Researchers from RAND and Indiana University created models to estimate the number of COVID-19 deaths that would have happened without...
News
Increased stroke risk linked with excess sitting in those under 60
Study highlights need for public health messaging directed at younger adults to be less sedentary.
News
Tackle obesity to drop risk for secondary cardiac event
‘It seems that obesity is not considered by physicians as a serious medical problem, which requires attention’ to lower risk for a secondary...
News
Injectable monoclonal antibodies prevent COVID-19 in trial
The cocktail of casirivimab and imdevimab reduced the relative risk of infection by 72% in patients at high risk of infection.
News
Summer campers spread COVID at home, follow-up finds
Transmission was more likely from some campers than others, according to a new report.
News
Diabetes drug’s new weight-loss indication fuels cost-benefit debate
Health plans’ coverage of semaglutide, branded as Wegovy – which has a $1,300-a-month price tag – is not a sure thing.